MedTrace Logo

Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement

NCT00657436 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2012-05-31

No results posted yet for this study

Summary

The purpose of the study is the evaluation of multiple biomarkers related to acute coronary syndromes, including myeloid-related protein 8/14 (MRP 8/14), along with established clinical markers, for early diagnosis and risk stratification in patients presenting with acute chest pain at the emergency department.

Study hypothesis: MRP 8/14, alone or together with other established or new biomarkers, increases the earliness, sensitivity, and specificity of diagnosing acute coronary syndromes.

Conditions

  • Myocardial Ischemia
  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Coronary Occlusion
  • Coronary Thrombosis

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Willibald Maier, MD · Cardiology, University Hospital Zurich

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00657436 on ClinicalTrials.gov